Sanofi Pasteur To File Quick Response To cGMP Violations At French Plant
This article was originally published in The Pink Sheet Daily
Executive Summary
An FDA untitled letter cites switch in pyrogen testing reagent and failure to thoroughly investigate problems and acknowledges Sanofi's commitment to corrections.